# Spruce Biosciences, Inc.: Form 8-K, filed Jan 5, 2022

- Company: [Spruce Biosciences, Inc.](/companies/sprb.md) (CIK 1683553)
- Form: 8-K
- Filed: 2022-01-05
- Accepted by EDGAR: Jan 5, 2022, 17:04 ET
- Period: 2021-12-29
- Accession: 0001564590-22-000432
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1683553/000156459022000432/sprb-8k_20211229.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1683553/000156459022000432/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1683553/000156459022000432/sprb-8k_20211229.htm

Filed Jan 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-000432. Last ingested by Listed: Nov 9, 2026, 17:52 ET. No prices; not investment advice.
